A NEW GENERATION OF CARDIAC MONITORING

Reliable insights. Scalable cardiac care.

FORESEE is developing a next-generation, battery-free intravascular sensing platform that combines multiple physiological measurements to support more informed, personalized heart failure management.

Conceptual illustration of four physiological measurements: pulmonary artery pressure, intrathoracic impedance, cardiac mechanics, and temperature.

4 parameters

Complementary physiological measurements

Battery-free

Wireless powering through volume conduction

~5 minutes

Target daily home monitoring routine

THE CLINICAL CHALLENGE

Heart failure is complex. Monitoring should reflect that.

Heart failure involves interacting changes in cardiovascular pressures, fluid status, and cardiac function. Yet existing implantable monitoring approaches often focus on a single physiological parameter.

FORESEE is developing a multiparametric platform designed to provide a more comprehensive view of a patient's cardiovascular condition, supporting more informed clinical decisions.

A changing condition

Patients can experience progressive deterioration and recurrent decompensation despite ongoing treatment.

Multiple mechanisms

Haemodynamics, thoracic fluid status and cardiac mechanics contribute complementary information.

More informed care

Comprehensive physiological information can support individualized clinical assessment and management.

Scalable, patient-centered care

Managing large heart failure populations requires monitoring models that enable safe, physician-guided patient self-management without overwhelming clinical teams.

THE FORESEE SOLUTION

Beyond single-parameter monitoring.

One intravascular implant. Multiple complementary physiological measurements.

FORESEE is developing a microsensing platform designed to capture pulmonary artery pressure, intrathoracic impedance, cardiac mechanics and temperature through a single implantable device.

EXPLORE THE CLINICAL NEED →
FORESEE MedTech multiparametric intravascular implant

OUR TECHNOLOGICAL ADVANTAGE

Innovation designed for reliability and scalability.

Our differentiation lies not only in what we measure, but in how we power, integrate and scale implantable sensing technology.

01 / MINIATURIZATION

Ultra-thin implant

A compact intravascular form factor designed to reduce the implant's internal component footprint.

02 / POWERING

Battery-free operation

Volume-conduction wireless power transfer without an implanted battery or conventional receiving coil.

03 / INTEGRATION

Multiparametric sensing

An architecture designed to integrate multiple sensing capabilities into a single implantable platform.

Advanced sensing, designed around everyday heart failure care.

HOW IT WORKS →

OUR FOUNDATION

From scientific innovation to medical technology.

FORESEE is a spin-off of Universitat Pompeu Fabra (UPF) - Barcelona. Its work builds on research in bioelectrical phenomena and wireless powering of implantable devices.

UPF spin-off

Translating university research into an implantable medical technology platform.

ERC research

Building on scientific work in volume conduction and implantable technologies.

€2.5M EIC Transition

European funding supporting technology maturation and validation.

Let's advance cardiac monitoring together.

FORESEE welcomes conversations with clinical partners, research collaborators, and investors interested in the future of heart failure monitoring.

Contact Us